DNA shapes itself to execute new functions

DNA can mimic protein functions by folding into elaborate, three-dimensional structures, according to a study from researchers at Weill Cornell Medicine and the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Federal program inadvertently promotes costlier drugs

A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.

Google, Cornell to partner in online security initiative

Cornell is one of four higher-education institutions in a new $12 million partnership with Google aimed at establishing New York City as the world leader in cybersecurity.

Shawon Debnath honored with Breakout Award

Shawon Debnath, a research associate in pathology and laboratory medicine at Weill Cornell Medicine, has been honored with a 2023 Tri-Institutional Breakout Award for Junior Investigators. 

Cornell Tech launches new product, technology leadership program

Cornell Tech in New York City will host the Product and Tech Executive Leadership Program in September.

Around Cornell

Health care subsidies for all immigrants a must: analysis

Recent uncertainties regarding the legal status of the DACA program underscore the urgency for policymakers to reassess long-standing restrictions on government-sponsored health care subsidies for immigrants.

Dr. Robert Harrington named dean of Weill Cornell Medicine

Dr. Robert A. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.

Cancers in distant organs alter liver function

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine.

Grant funds study of cannabis effects on HIV-infected brain tissue

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.